Abstract
Introduction: Lateral epicondylitis (LE) a common work related injury. Sixteen per cent of patients with LE require work restrictions and frequently (4–5%) need prolonged absences from work, with a median 29 days missed per patient (1, 2). LE represents a significant socio-economic burden due to losses in individual productivity and health care costs. Autologous tenocyte injection (ATI) has recently been developed for the treatment of LE including patients who have failed other treatments for this condition. The objective of this study is to investigate if workers compensation patients with LE were able to return to work after ATI treatment.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
